The Globe and Mail reports in its Friday edition that RBC Capital Markets analyst Paul Treiber continues to rate Kinaxis "outperform." The Globe's David Leeder writes in the Eye On Equities column that Mr. Treiber advanced his share target by $10 to $220. Analysts on average target the shares at $222.46. Mr. Treiber says in a note: "We attended Kinaxis's user conference this week. The event was the most impactful that we've attended, considering: 1) demand appears broad-based and resilient; 2) new products expand Kinaxis's total addressable market; and 3) partners are scaling Kinaxis into additional verticals and the mid-market. This suggests to us high visibility to Kinaxis seeing SaaS growth accelerate to its mid-term 30-per-cent target. Kinaxis represents a compelling long-term growth story. We believe SaaS growth acceleration may drive valuation multiple expansion." The Globe reported on March 6 that Scotia Capital analyst Kevin Krishnaratne was sticking with his "sector outperform" call for Kinaxis, which could then be had for $171.10. The Globe reported on May 6 that BMO Capital Markets analyst Thanos Moschopoulos had reaffirmed his "outperform" recommendation for Kinaxis. It was then worth $179.